Laboratory News and Research

RSS

PressureWire Aeris technology now available to hospitals using Horizon Cardiology Hemo solution

St. Jude Medical, Inc. announced today its wireless PressureWire™ Aeris technology, which aids in the diagnosis and treatment of coronary artery blockages by measuring Fractional Flow Reserve (FFR), will now be available to hospitals using the McKesson Horizon Cardiology Hemo™ solution.

24 Feb 2010

ACS re-verifies Saint Marys Hospital and Mayo Eugenio Litta Children’s Hospital as Level 1 trauma centers

Saint Marys Hospital and Mayo Eugenio Litta Children’s Hospital recently received re-verification as Level 1 adult and pediatric trauma centers, respectively, by the American College of Surgeons (ACS). The ACS verification recognizes Mayo Clinic’s dedication to providing the highest-quality trauma care for all injured patients. Mayo Eugenio Litta Children’s Hospital is the first children’s hospital in Minnesota to receive verification as an independent level one pediatric trauma center.

24 Feb 2010

Mouse study provides new way to test novel therapies for liver infections

How do you study-and try to cure in the laboratory-an infection that only humans can get? A team led by Salk Institute researchers does it by generating a mouse with an almost completely human liver.

24 Feb 2010

XIFIN joins PMC to help evolve reimbursement policies and practices that support personalized medicine

XIFIN Inc., the leading provider of revenue cycle management for diagnostic service providers, has joined the Personalized Medicine Coalition, an educational and advocacy group dedicated to advancing the understanding and adoption of personalized medicine, defined as the application of genomic and molecular data to better target the delivery of healthcare by determining a person's predisposition to a particular disease or condition.

24 Feb 2010

Alliance Biosciences to provide engineering and biosafety guidance for Nyumbani's HIV/TB diagnostic facility

Alliance Biosciences reached an agreement with the Nyumbani Children's Home in Kenya to provide engineering and biosafety guidance to Nyumbani's planned HIV/TB diagnostic facility.

24 Feb 2010

Winner of 2010 Anatrace Membrane Protein Award

Affymetrix, Inc. today announced that Professor Tom Rapoport of Harvard Medical School and Howard Hughes Medical Institute is the winner of the 2010 Anatrace Membrane Protein Award.

24 Feb 2010

Genocea Biosciences secures licensing to extensive HSV antigen patent estate

Genocea Biosciences, a leading vaccine discovery and development company, today announced that it has licensed an extensive patent estate from the University of Washington and the Fred Hutchinson Cancer Research Center for 25 pending and issued patents related to herpes simplex virus (HSV) type 2 antigens. The addition of these patents complements the novel antigens discovered by Genocea’s unique and proprietary antigen discovery technology. The combination of Genocea’s novel intellectual property with the patent estate from the University of Washington provides the Company with a broad compendium of HSV antigen patents.

24 Feb 2010

A1C lab test can help in combating diabetes

Approximately 57 million Americans are on the brink of diabetes. Yet research tells us that there is much we can do to keep it from progressing to full-blown diabetes. Lab tests can help us get a grip on the disease, says the American Clinical Laboratory Association President Alan Mertz.

24 Feb 2010

ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI

At the 17th Conference on Retroviruses and Opportunistic Infections (CROI), ViiV Healthcare presented new data across its broad range of investigational and current medicines for the treatment of HIV/AIDS. Highlighted data at the conference included an oral presentation on the investigational integrase inhibitor, S/GSK1349572, as well as data presentations on SELZENTRY® (maraviroc) and EPZICOM® (abacavir/lamivudine).

24 Feb 2010

SRI International awarded $3.8M BARDA contract to develop a radiation assessment device

SRI International, an independent nonprofit research and development institute, has received a $3.8M contract from the Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA). SRI will research and develop a device to triage individuals who may have been exposed to ionizing radiation after a radiological or nuclear incident.

24 Feb 2010

FDA grants EUA for Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay in CLIA high complexity laboratories

Longhorn Vaccines & Diagnostics today announced it has been granted Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay™ in CLIA high complexity laboratories. . The Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay™ is a ready-use assay that requires no mixing prior to use and has been authorized for use on the ABI 7500.

24 Feb 2010

New Barts Cancer Research UK Centre launched

A new cancer centre, launched today, puts London at the forefront of cancer research.

23 Feb 2010

Cantimer, Advanced Instruments announce license and product development agreement

Cantimer, Inc., and Advanced Instruments, Inc. today jointly announced that the two companies had signed a license and product development agreement. Under the terms of the license agreement, Advanced Instruments received an exclusive license to Cantimer's unique sensor technology for select applications in the biotech market.

23 Feb 2010

DNA interval in unexplored region of human genome increases risk for coronary artery disease

Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have learned how an interval of DNA in an unexplored region of the human genome increases the risk for coronary artery disease, the leading cause of death worldwide.

23 Feb 2010

Sound-based lasers could lead to development of high-resolution biomedical diagnostic devices

Physicists have taken major step forward in the development of practical phonon lasers, which emit sound in much the same way that optical lasers emit light. The development should lead to new, high-resolution imaging devices and medical applications.

23 Feb 2010

NIH awards Sanaria Phase II SBIR grant to develop genetically attenuated, whole parasite malaria vaccine

Sanaria Inc. has received additional support from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health in the form of a Phase II Small Business Innovation Research (SBIR) Grant. The three-year award totaling approximately $3 million will support collaborative research by investigators at Sanaria and Columbia University.

23 Feb 2010

BrainStorm Cell Therapeutics, Hadassah Medical Center sign collaborative agreement for ALS clinical trials

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is extremely pleased to announce that it has entered into a collaborative agreement with Hadassah Medical Center to conduct its ALS clinical trials at the Hadassah Ein Kerem Hospital.

22 Feb 2010

Cord Blood America announces aim to be world's largest stem cell storage facility

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, for families nationwide and internationally, said today in an interview of Matthew Schissler, co-founder and CEO, by analyst Francis Gaskins, that its goal is to be the world's largest stem cell storage facility.

22 Feb 2010

HHS Secretary reviews H1N1 response at NACCHO conference

Thank you, Tom. I also want to thank NACCHO for hosting this important conference and for inviting me to speak here today. Public health is a top priority for this administration. So is strengthening our partnerships across government. So I’m glad I could come talk with you about how we can work together to keep Americans healthy and safe.

22 Feb 2010

BHL litigation against Health Diagnostic Laboratory: Celera addresses business impact

Celera Corporation today provided information on litigation filed by Berkeley HeartLab, Inc. (“BHL”), Celera’s wholly-owned subsidiary, against Health Diagnostic Laboratory, Inc. and several former employees of BHL, including five sales representatives who left the Company on January 1, 2010, and two former laboratory employees.

22 Feb 2010

Laboratory News and Research

PressureWire Aeris technology now available to hospitals using Horizon Cardiology Hemo solution

ACS re-verifies Saint Marys Hospital and Mayo Eugenio Litta Children’s Hospital as Level 1 trauma centers

Mouse study provides new way to test novel therapies for liver infections

XIFIN joins PMC to help evolve reimbursement policies and practices that support personalized medicine

Alliance Biosciences to provide engineering and biosafety guidance for Nyumbani's HIV/TB diagnostic facility

Winner of 2010 Anatrace Membrane Protein Award

Genocea Biosciences secures licensing to extensive HSV antigen patent estate

A1C lab test can help in combating diabetes

ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI

SRI International awarded $3.8M BARDA contract to develop a radiation assessment device

FDA grants EUA for Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay in CLIA high complexity laboratories

New Barts Cancer Research UK Centre launched

Cantimer, Advanced Instruments announce license and product development agreement

DNA interval in unexplored region of human genome increases risk for coronary artery disease

Sound-based lasers could lead to development of high-resolution biomedical diagnostic devices

NIH awards Sanaria Phase II SBIR grant to develop genetically attenuated, whole parasite malaria vaccine

BrainStorm Cell Therapeutics, Hadassah Medical Center sign collaborative agreement for ALS clinical trials

Cord Blood America announces aim to be world's largest stem cell storage facility

HHS Secretary reviews H1N1 response at NACCHO conference

BHL litigation against Health Diagnostic Laboratory: Celera addresses business impact

Lab Diagnostics and Automation - Second Edition eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News